Oxygen generator for medical applications (USIC)
Program Document
·
OSTI ID:1035841
The overall Project objective is to develop a portable, non-cryogenic oxygen generator capable of supplying medical grade oxygen at sufficient flow rates to allow the field application of the Topical Hyperbaric Oxygen Therapy (THOT{reg_sign}) developed by Numotech, Inc. This project was sponsored by the U.S. Department of Energy Global Initiatives for Proliferation Prevention (GIPP) and is managed by collaboration between Sandia National Laboratories (SNL), Numotech, Inc, and LLC SPE 'Spektr-Conversion.' The project had two phases, with the objective of Phase I being to develop, build and test a laboratory prototype of the membrane-pressure swing adsorber (PSA) system producing at 15 L/min of oxygen with a minimum of 98% oxygen purity. Phase II objectives were to further refine and identify the pre-requisites needed for a commercial product and to determine the feasibility of producing 15 L/min of oxygen with a minimum oxygen purity of 99%. In Phase I, Spektr built up the necessary infrastructure to perform experimental work and proceeded to build and demonstrate a membrane-PSA laboratory prototype capable of producing 98% purity oxygen at a flow rate of 5 L/min. Spektr offered a plausible path to scale up the process for 15 L/min. Based on the success and experimental results obtained in Phase I, Spektr performed work in three areas for Phase II: construction of a 15 L/min PSA; investigation of compressor requirements for the front end of the membrane/PSA system; and performing modeling and simulation of assess the feasibility of producing oxygen with a purity greater than 99%. Spektr successfully completed all of the tasks under Phase II. A prototype 15 L/min PSA was constructed and operated. Spektr determined that no 'off the shelf' air compressors met all of the specifications required for the membrane-PSA, so a custom compressor will likely need to be built. Modeling and simulation concluded that production of oxygen with purities greater than 99% was possible using a Membrane-PSA system.
- Research Organization:
- Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC04-94AL85000
- OSTI ID:
- 1035841
- Report Number(s):
- SAND2012-1703P
- Country of Publication:
- United States
- Language:
- English
Similar Records
Field application of the Numobag as a portable disposable isolation unit and for treating chemical, radiological or biologically induced wounds.
Hybrid membrane--PSA system for separating oxygen from air
Evaluation of hyperbaric filtration for fine coal dewatering. Tenth quarterly technical progress report, January 1, 1995--March 31, 1995
Conference
·
Thu Mar 31 23:00:00 EST 2005
·
OSTI ID:969868
Hybrid membrane--PSA system for separating oxygen from air
Patent
·
Mon Jan 24 23:00:00 EST 2011
·
OSTI ID:1013025
Evaluation of hyperbaric filtration for fine coal dewatering. Tenth quarterly technical progress report, January 1, 1995--March 31, 1995
Technical Report
·
Fri Sep 01 00:00:00 EDT 1995
·
OSTI ID:111930